These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 7594319)

  • 1. Suppression of Acid Secretion by Lansoprazole and its Effects on Helicobacter pylori. II. Poster presentations from the 2nd International Colloquium on Proton Pump Inhibitors. Houston, Texas, September 29, 1994.
    J Clin Gastroenterol; 1995; 20 Suppl 2():S1-135. PubMed ID: 7594319
    [No Abstract]   [Full Text] [Related]  

  • 2. Proceedings of the 2nd International Colloquium on Proton Pump Inhibitors.
    J Clin Gastroenterol; 1995; 20 Suppl 1():S1-51. PubMed ID: 7673606
    [No Abstract]   [Full Text] [Related]  

  • 3. Effectiveness of quadruple therapy using lansoprazole, instead of omeprazole, in curing Helicobacter pylori infection.
    de Boer WA; van Etten RJ; Lai JY; Schneeberger PM; van de Wouw BA; Driessen WM
    Helicobacter; 1996 Sep; 1(3):145-50. PubMed ID: 9398895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of proton-pump inhibitors in complicated ulcer disease and upper gastrointestinal tract bleeding.
    Howden CW
    Am J Health Syst Pharm; 1999 Dec; 56(23 Suppl 4):S5-11. PubMed ID: 10597118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton pump inhibitors for Helicobacter pylori eradication in patients with peptic ulcer.
    Yamamoto I; Fukuda Y; Okui M; Tamura K; Shimoyama T
    J Clin Gastroenterol; 1995; 20 Suppl 1():S38-42. PubMed ID: 7673613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lansoprazole: pharmacokinetics, pharmacodynamics and clinical uses.
    Gremse DA
    Expert Opin Pharmacother; 2001 Oct; 2(10):1663-70. PubMed ID: 11825309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptic ulcer therapy with lansoprazole and Helicobacter pylori eradication.
    Ogoshi K; Kato T; Sakagawa T
    J Clin Gastroenterol; 1995; 20 Suppl 2():S97-9. PubMed ID: 7594354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helicobacter pylori eradication increases nocturnal acid breakthrough.
    van Herwaarden MA; Samsom M; Smout AJ
    Aliment Pharmacol Ther; 2000 Jul; 14(7):961-2. PubMed ID: 10886054
    [No Abstract]   [Full Text] [Related]  

  • 9. [Helicobacter pylori eradication: modified triple therapy with lansoprazole].
    Müller P; Simon B
    Fortschr Med; 1996 Dec; 114(35-36):497-9. PubMed ID: 9119351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lansoprazole and omeprazole in the treatment of acid peptic disorders.
    Blum RA
    Am J Health Syst Pharm; 1996 Jun; 53(12):1401-15. PubMed ID: 8781686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of a proton pump inhibitor-based therapy on Helicobacter pylori strain selection.
    Hazell SL; Mitchell HM; Hanna G; Daskalopoulos G
    Eur J Clin Microbiol Infect Dis; 1997 Jul; 16(7):530-2. PubMed ID: 9272389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative study of proton pump inhibitors].
    Herszényi L; Tulassay Z
    Orv Hetil; 2001 Sep; 142(36):1953-61. PubMed ID: 11680100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helicobacter pylori: factors affecting eradication and recurrence.
    Vakil N
    Am J Gastroenterol; 2005 Nov; 100(11):2393-4. PubMed ID: 16279890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lansoprazole: a comprehensive review.
    Zimmermann AE; Katona BG
    Pharmacotherapy; 1997; 17(2):308-26. PubMed ID: 9085323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [What are the indications for proton pump inhibitors? R. Arnold, Marburg, elaborates on the clinical aspects of the controversy regarding lansoprazole. Interview by Gerrit Lichtenberg].
    Arnold R
    Fortschr Med; 1994 Jan; 112(1-2):44-5. PubMed ID: 8144120
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapeutic effects of lansoprazole on peptic ulcers in elderly patients.
    Murakami M; Saita H; Takahashi Y; Kusaka S; Asagoe K; Dekigai H; Matsumoto M; Seki M; Mizuno M; Maeda S
    J Clin Gastroenterol; 1995; 20 Suppl 2():S79-82. PubMed ID: 7594348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Polaprezinc].
    Kuwayama H; Takahashi M; Suzuki K; Suga M; Takata H; Ohara T; Koizumi K; Kiriyama Y
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():717-20. PubMed ID: 11979877
    [No Abstract]   [Full Text] [Related]  

  • 18. Synergic interactions of macrolides and proton-pump inhibitors against Helicobacter pylori: a comparative in-vitro study.
    Malizia T; Tejada M; Marchetti F; Favini P; Pizzarelli G; Campa M; Senesi S
    J Antimicrob Chemother; 1998 Mar; 41 Suppl B():29-35. PubMed ID: 9579710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continued use of the proton-pump inhibitor lansoprazole following Helicobacter pylori eradication.
    Claessens AA; Heerdink ER; van Eijk JT; Lamers CB; Leufkens HG
    Eur J Clin Pharmacol; 2000 Jan; 55(10):773-6. PubMed ID: 10663458
    [No Abstract]   [Full Text] [Related]  

  • 20. [Two step therapy for education of Helicobacter pylori].
    Matsukura N
    Nihon Shokakibyo Gakkai Zasshi; 1997 Aug; 94(8):569. PubMed ID: 9284449
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.